ADV LIFE SCIENCES COM STK USD0.01 (ADLS)

0.00
OTC Markets
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.01
Exchange OTC Markets
Shares Outstanding 10.79B
Div & Yield N.A. (N.A)

Hollis-Eden Namesake Fired 'For Cause'

Hollis-Eden founder and CEO Richard Hollis was fired 'for cause' by his board, triggering a clause in his contract that strips him of millions of dollars in severance payments.

Health Winners & Losers: Johnson & Johnson

The company won a favorable ruling in its patent case against Boston Scientific.

Advanced Life, Wyeth Ink Marketing Deal

Advanced Life Sciences completed antibiotic cethromycin's filing with U.S. regulators and signed an Asian marketing deal with Wyeth.

Friday's Small-Cap Winners & Losers

Amcol falls on an earnings miss.

Tuesday's Health Winners & Losers

Cell Therapeutics climbs on positive preliminary study results.

Biotech Notebook: Medarex, Panacos, Advanced Life

Medarex refuses to face reality about the trial failure of its skin cancer drug.

Feuerstein's Biotech-Stock Mailbag

Micro-cap Advanced Life Sciences faces a tough road.

Thursday's Health Winners & Losers

Advanced Life climbs on study results.

Tuesday's Small-Cap Winners & Losers

Xoma climbs on a licensing deal with Pfizer.

Monday's Small-Cap Winners & Losers

Local.com soars on a patent award.

Thursday's Health Winners & Losers

Corcept Therapeutics climbs on positive study data.

Wednesday's Health Winners & Losers

Health care stocks edge up, helped by successful drug studies and stock offerings.

New Antibiotic Awaits Fate

Advance Life Sciences and Sanofi-Aventis await the FDA's decision on Ketek.

Health Stocks in Motion: Possis

GTC Biotherapeutics is dropping 17%.